Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response
10.1186/1476-4598-8-94
Saved in:
Main Authors: | Bhuvaneswari R., Gan Y.Y., Soo K.C., Olivo M. |
---|---|
Other Authors: | SURGERY |
Format: | Article |
Published: |
BioMed Central Ltd.
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/143358 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model
by: Bhuvaneswari, R., et al.
Published: (2014) -
Combination of angiogenesis inhibitors increases the anti-tumor efficacy of photodynamic therapy in a human bladder tumor xenograft model
by: Bhuvaneswari, R., et al.
Published: (2014) -
Combined use of anti-VEGF and Anti-EGFR monoclonal antibodies with Photodynamic therapy suppresses tumor growth in an in vivo tumor model
by: Bhuvaneswari, R, et al.
Published: (2020) -
The effect of photodynamic therapy on tumor angiogenesis
by: Bhuvaneswari, R., et al.
Published: (2014) -
Targeted therapy of cancer using photodynamic therapy in combination with multi-faceted anti-tumor modalities
by: Olivo, M., et al.
Published: (2014)